ArticleCancer management and research2025

Diagnostic Value of FPSAD and PI-RADS v2.1 for Clinically Significant Prostate Cancer in Patients with tPSA Levels of 4-10 ng/mL.

Wei Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.